Innovative Brain Implant Empowers ALS Patients with Thought Control
Written on
Chapter 1: Introduction to Brain-Computer Interfaces
Recent advancements in technology have paved the way for brain-computer interfaces (BCIs) that significantly enhance the quality of life for individuals with paralysis, such as those affected by amyotrophic lateral sclerosis (ALS). These innovative devices allow users to control computers and smart devices purely through their thoughts.
Section 1.1: Graham Felstead's Journey
Graham Felstead, who first experienced weakness in his left arm in 2016, was diagnosed with ALS two years later. This debilitating neurological condition leads to the gradual loss of voluntary muscle control, ultimately necessitating complete reliance on caregivers for daily tasks. However, after being implanted with a cutting-edge device in August 2019, Felstead has regained a measure of independence. This implant establishes a wireless connection to his computer and other smart devices, enabling him to browse the internet, manage emails, and draft documents using only his thoughts.
“The device has allowed me to be productive again, including shopping, banking, and delegating tasks among the Rotary Club members with whom I volunteer,” he stated in a press release from Synchron, the company responsible for the implant's development.
Section 1.2: The Mechanics of the Implant
Felstead and another ALS patient, Philip O’Keefe, are pioneers in using Synchron’s experimental BCI. Unlike traditional methods that require invasive brain surgery, this implant is inserted into a major neck vein through a minor incision, thus avoiding direct brain intervention. O’Keefe, who received his implant in April, can independently perform work tasks and engage in other activities.
The CEO of Synchron, Thomas Oxley, MD, PhD, likens the device to “Bluetooth for the brain.” He emphasizes, “The significant difference with our approach is that we do not use needles in the brain or on its surface.” Instead, the implant remains within the blood vessel, where it picks up brain activity via small electrodes on its surface.
Chapter 2: Training and Performance
Learning to operate this system required thorough training with Synchron’s engineers. After three months, both Felstead and O’Keefe were able to use the device unaided in their homes in Australia. They can type at approximately 14 and 20 characters per minute, respectively, with a high accuracy rate of 92% to 93%. Their experiences were documented in a feasibility study published in the Journal of NeuroInterventional Surgery.
This video discusses how a brain implant enables individuals to turn thoughts into text, showcasing the groundbreaking technology behind BCIs.
Section 2.1: Safety and Longevity
Synchron's implant is considered safe, as the procedure for inserting heart stents has been practiced for decades with a solid safety record. However, some patients may experience complications such as rejection or thrombosis. While Felstead and O’Keefe have not faced these issues yet, the company continues to monitor their conditions. Despite the device's design for long-term use, Synchron has plans for its removal if necessary.
Unlike conventional BCIs that involve invasive procedures and have limited lifespan due to inflammation, Synchron's Stentrode offers a more sustainable solution. Current brain-computer interfaces only last around five years, while Synchron aims to provide a device that lasts a lifetime.
Chapter 3: Future Prospects
Synchron is hopeful that its BCI will be the first commercially available device of its kind. The company is actively enrolling patients for clinical trials in Australia and the United States.
This video highlights how brain implants combined with AI technology have allowed individuals with paralysis to regain their voice, showcasing the potential impact of these advancements.
Robert Kirsch, PhD, an expert in brain-computer interfaces who is not associated with Synchron, has described the company's approach as “elegant” for simpler tasks like typing. However, he notes that the device's limited electrode count may restrict its capabilities compared to more invasive options.
Despite these limitations, Oxley envisions a future where the Stentrode could help paralyzed individuals control robotic limbs, thereby enhancing their freedom and independence. Felstead himself has remarked, “Using the Stentrode has been life-altering. It’s incredible to regain this level of independence.”